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Direct compression is the most efficient process used in tablet manufacturing because it is the fastest, simplest and least expensive tablet-compression procedure. 1) However, although this technique seems quite simple, it requires that different properties be observed simultaneously: -good flowability of the materials, -a suitable bulk density of the powder, in order that the correct amount of drug may be fed into a die cavity, -appropriate particle size distribution, and -good compressibility of the powder.
Many drug crystals do not exhibit these properties: they have poor flowability and compressibility. 2) In tablet making from these materials, possible solutions may be as follows:
-the use of wet granulation (if this is possible with regard to the drug stability), -the use of direct tablet making with a good excipient, or -the use of direct pressing with spherical crystals or crystal agglomerates of drug material with good flowability and compactibility properties.
The production of spherical crystals has recently gained great attention and importance, due to the fact that the crystal habit (form, surface, size and particle size distribution) can be modified during the crystallization process. In consequence of such modifications in the crystal habit, certain parameters of materials can also be changed: bulk density, flow property, compactibility, dissolution rate, stability, 3) etc. "Spherical crystallization" was defined by Kawashima as "an agglomeration technique that transforms crystals directly into a compacted spherical form during the crystallization process." 4) A few methods are to be found in the literature. The typical spherical crystallization process employs three solvents: one is the substance dissolution medium, another is a medium which partially dissolves the substance, and the third is the wetting solvent for the substance. Of course, the traditional crystallization processes (salting-out precipitation, cooling crystallization, crystallization from the melting, etc.) can also be used to produce spherical crystal agglomerates.
5)
The traditional crystallization process is carried out by controlling the physical and chemical properties and can be called the non-typical spherical crystallization process.
Many drugs which do not have suitable technological properties have been transformed successfully into spherical agglomerates with good flowability and compressibility during manufacturing (salicylic acid, tolbutamide, dibasic calcium phosphate anhydrous, norfloxacin, DL-methionine, phenytoin, ferrous sulfate, etc.). [6] [7] [8] [9] [10] [11] [12] [13] Other materials are currently awaiting such transformation.
A few years ago Aoki et al. (Japan) and Deshpande et al. (India) were employed in making spherical ASA crystals from a mixture of heptane-pentane-methanol 14) and a mixture of methanol-chloroform-acid buffer.
15) The commercial ASA crystals are tetragonal and prism-shaped, with different sizes and particle size distribution. Their flow property is poor due to the crystal habit and the electrostatic charge. Since ASA crystals can be compressed to tablets (e.g., effervescent or chewable) only via direct tablet-making methods (stability!), good flowability, cohesivity and tablettability of the crystals are very important.
Therefore in the work reported here, ASA crystals were developed by means of non-typical and typical spherical crystallization processes by different solvent mixtures.
Experimental
Development of Spherical ASA Crystals Three different samples were produced by variation of the experimental conditions. The experiments were carried out in a mechanically stirred tank with a volume of 500 ml. A Julabo thermostat with computer control was used for the cooling process. A nontypical spherical crystallization process was used for the samples ASA 1 and ASA 2. ASA 3 was developed, however, by the typical spherical crystallization procedure.
ASA 1: 160 g of ASA was dissolved in 500 ml of ethanol (40% v/v) at 60°C, followed by cooling at 1°C/min to 20°C with stirring (200 rpm). * To whom correspondence should be addressed. ASA 2: 160 g of ASA was dissolved in 500 ml of ethanol (40% v/v) at 60°C, followed by cooling at 0.5°C/min to 20°C with stirring (200 rpm).
ASA 3: 121.6 g of ASA was dissolved in 225 ml of ethanol (40% v/v) at 50°C, and a carbon tetrachloride-water mixture (4% w/v) was added to the solution, followed by cooling at 0.6°C/min to 20°C with stirring (200 rpm). The ASA 3 crystallization process can be followed in Fig. 1 .
Particle Size Analysis Determination of the particle size (length, breadth and roundness) was carried out with a Laborlux S light microscope and a Quantimet 500MC (Q500MC) image processing and analysis system (LEICA Cambridge, Ltd., U.K.).
Roundness is a shape factor that provides information on the circularity of particles. It is calculated by software according to the following formula:
The perimeter was calculated from the horizontal and vertical projections, with an allowance for the number of corners. An adjustment factor of 1.064 corrected the perimeter for the effect of the corners produced by digitization of the image. When roundness value is close to one, the particles are nearly spherical.
Morphological Study
The ASA crystals were observed with a scanning electron microscope (Hitachi Scientific Instrument, Ltd., Tokyo, Japan). A Polaron sputter coating apparatus (Polaron Equipment, Ltd., Greenhill, U.K.) was applied to induce electric conductivity on the surface of the sample. The air pressure was 1.3-13 mPa.
Friability Test ASA3 sample was investigated by Heberlein apparatus (Flisa, Le Locle, Switzerland). Five grams of sieved sample (Ͻ0.32 mm) was put into the apparatus and 100 revolutions were performed. After this process the fine particles were removed by sieve (Ͻ0.32 mm) and the percentage of weight loss was calculated.
Determination of Salicylic Acid (SA) Contents of the ASA Samples The SA contents of the samples were controlled by a spectrophotometer (Spectromom, MOM, Budapest, Hungary); 0.250 g of sample was dissolved in 25 ml of ethanol (96%) and diluted with water up to 100 ml. After additional dilution (5 ml aliquotϩ95 ml water), the absorbance was read at 297 nm for SA. The testing was done with a near-infrared spectroscope.
Dissolution Test The investigations were performed with the USP dissolution method (paddle). The medium was artificial gastric juice (pHϭ1.2) at a temperature of 37Ϯ0.5°C. The paddle speed was 50 rpm. The samples were analyzed spectrophotometrically (Spectromom) at 276 nm. The dissolution rate of ASA was determined from the capsules, and the hard gelatin capsules (No. 1) were filled with 100 mg of ASA crystals.
Study of Flow Properties
The flow time was determined with a powder testing instrument (PTG-51, Pharma Test Apparatebau GmbH, Hamburg). 
The Carr index reflects the compactibility of a powder, and there is a correlation between this index and the flowability of the crystals. 17) Compactibility and Cohesiveness The Stampfvolumeter measurements allow calculation of the compactibility and cohesiveness values via the modified Kawakita equation 18, 19) : (3) where N is the number of taps, C is the degree of volume reduction, and a and b are constants: a describes the degree of volume reduction at the limit of tapping and is called the compactibility; 1/b is considered to be a constant related to cohesion and is called the cohesiveness. C is calculated via the following equation, and graphs of N/C vs. N are plotted. (4) The compactibility a and cohesiveness 1/b are obtained from the slope (1/a) and the intercept (1/ab) of the plot of the modified Kawakita equation.
Recording Diffuse-Reflectance Spectra Near-infrared spectroscopy furnishes useful information for qualitative and quantitative analysis of materials without invasive sample preparation. It can be used for the control of differences among the particle forms of the samples. 20) Diffuse reflectance was measured by a Hitachi (Japan) U-3501 UV/VIS/NIR spectrophotometer equipped with integrating sphere (dϭ60 mm) and PbS detector. The reflectance (R%) of samples was determined in the wavelength range 200-2500 nm using a 5 mm layered cell R%ϭ(I R /I 0 ) · 100 (5) where I R is the intensity of the diffusely reflected light collected by the integrating sphere and I 0 is the intensity of the incident light.
21)
Production of ASA Tablets The materials without any excipients were pressed into tablets by a KORSCH EKO single punch tablet machine (Emil Korsch Maschinenfabrik, Berlin, Germany). The compression tools were single flat punches 10 mm in diameter. The rate of compression was 30 tablets/min with a pressure force of 18 kN, at an air temperature 24°C and an air relative humidity of 30%.
Investigation of ASA Tablets Investigations were carried out 24 h after pressing. Tablet weight was measured to the order of 0.1 mg. The relative standard deviation (RSD) was calculated from 20 data points and breaking hardness was determined using a Heberlein apparatus (Flisa, Le Locle, Switzerland) (20 tablets).
Statistical Calculation The standard deviation and the regression analysis were carried out with the Statgraphics package (copyright STSC Inc. and Statistical Graphics Co. U.S.A.); the confidence limit was 95%.
Results and Discussion
The ASA1 crystals were tetragonal monocrystals with plane boundaries (Fig. 2) . The cooling rate of 1°C/min resulted in formation of a great number of seeds and did not act favourably either on crystal growth or on seed build-up.
Decreasing the cooling rate (0.5°C/min) (ASA2) led to the appearance of a small number of crystal agglomerates beside the monocrystals (Fig. 3) . Due to the slow cooling, the monocrystals were very large and well-developed. Agglomerates were formed by the accidental encounter of 4-5 crystal seeds. Crystals built up at one point have a habit characteristic of monocrystals.
Further reduction of the cooling rate and changes in the other parameters of crystallization did not cause many changes in the formation of agglomerates either. For example the use of higher stirring speed decreased the possibility of the agglomeration of ASA2 monocrystals but increased the danger of crystal breakage. Let us remark here that commercially available ASA products have a habit similar to that of ASA1 and ASA2 products.
During the formation of ASA3, the crystals were transformed into spherical agglomerates (Fig. 4) . The process was
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Fig. 1. Cooling Curves of Crystallization Process of ASA3
A, cooling curve of equipment; B, cooling curve of solution; 1, dissolution of ASA crystals with addition of a carbon tetrachloride-water mixture (4% w/v) to the solution; 2, appearance of ASA crystals. the typical spherical crystallization (agglomeration) with three solvents (ethanol-water-carbon tetrachloride). In the three-solvent system the dissolved ASA was carried in the emulsion drops. Due to the effect of diffusion, the ethanol molecules left the emulsion drop and entered the aqueous phase through the emulsion film. The drop became oversaturated with respect to the ASA, and the in situ seed-formation started at 37°C (see Fig.1 ), followed by crystal formation, which was also influenced by the cooling and mixing rates. Thus, in this process it was not the accidental encounter of the crystals which resulted in the formation of crystal agglomerates. As a matter of fact, crystallization in emulsion drops was the case here, where the driving force was oversaturation caused by solvent diffusion. Although the built-up ASA crystals had a habit characteristic of monocrystals, the size of the agglomerates did not exceed the size of monocrystals and crystal agglomerates produced by non-typical spherical crystallization. ASA3 agglomerates were very hard, open structures. Their friability, which is very important during further processing, was very favorable. The friability of the ASA3 sample was found to be 6.24Ϯ0.45%, while the maximum friability of granules is usually limited to 20% in pharmacopoeias.
The length, breadth and roundness of the samples are de- tailed in Table 1 . The different crystallization processes strongly influenced the habit of the crystals or their agglomerates. A faster cooling process resulted in very small crystals (ASA1) with an unfavorable roundness value. Slower cooling helped the build-up of crystal agglomerates, but they were few in number and the structure was built up only partly (ASA2). Table 1 shows that ASA3 had the best roundness value. The ASA and salicylic acid content of the samples were qualified by NIR method. The diffuse-reflectance spectra of the ASA1 and ASA3 samples in the wavelength range of 200-350 nm was the same, which can be attributed to the uniform ASA content of the samples (Fig. 5) . In this range only the ASA2 sample showed a small peak for the salicylic acid as a decomposition product. The amount of the salicylic acid determined by spectrophotometer was 1.02%. In spite of the higher temperature, the decomposition of ASA2 was low because the crystallization time was only about 1 hour. The data for the slower cooling rate (0.1°C/min) and the longer process time (about 5 h) showed higher salicylic acid content in the sample (about 10%). Between 350-2500 nm ASA2 and ASA3 samples with larger particle sizes and the best values of roundness showed smaller diffuse reflectances than that of ASA1 with a smaller particle size and a unfavourable roundness value.
As the dissolution rate of the samples was basically influenced by particle size, this was also checked. It is clearly shown in Fig. 6 that the dissolution rate of the samples was almost the same, and only the ASA1 crystals, which have a small particle size and consequently a great surface, showed more rapid dissolution at the beginning of the examination.
A very important fact to be pointed out is that the spherical crystal agglomerates of ASA3 did not exert unfavourable influence on the dissolution rate.
The change in the habit of the crystals was reflected in the flowability of the samples. The spherical ASA3 had 'excellent' flow properties, as shown by the flow time and the Carr index (5-15%) ( Table 2 ). The flow time of the prism-shaped monocrystals of ASA1 could not be determined with the Pharmatest apparatus because the substance did not flow from the funnel of the apparatus. The Carr index of ASA1 was very high (19.99%) . This means 'fair to passable' (18-21%) flow properties.
The data from the modified Kawakita equation can be seen in Table 3 . The compactibilities (a) of ASA2 and ASA3 hardly differed; the compactibility of ASA1 was poorer. The cohesiveness (1/b) of ASA3 was outstanding, while those of the other two samples were higher and more disadvantageous. ASA3, which contained spherical crystals, had the best flowability, compactibility and cohesivity properties. ASA1, which did not form spherical agglomerates, gave the worst results. Hence, the transformation of commercial ASA crystals into spherical agglomerates led to improved flowability and compactibility. For ASA which did not undergo complete agglomeration, investigation revealed worse technological parameters.
As ASA samples were developed for direct tabletting, the preformulation results to date were completed with tablettability studies. The samples were compressed to tablets without excipient and the physical parameters of the tablets were determined (Table 4) . During the pressing of the ASA1 crys- tals great friction was indicated by a powerful machine sound. The die cavity was filled unevenly due to the unfavourable habit of the crystals and their electrostatic charge.
In consequence of this a high degree of pressure force variation could be observed, which also influenced the other parameters, thus, e.g., deviation from the theoretical mass was high and weight variation exceeded 2%. The ASA2 sample, which has a greater particle size and is only partially spherical, exhibited better properties of compressibility. The machine sound caused by friction became less intense but the weight variation value of the tablet was still over 2%, which is related to the great cohesivity value of the crystals. The latter can be attributed not only to the shape and size parameters of the crystals but also to their surface properties. The results obtained with tablets compressed from ASA3 were in harmony with the values of flow property, compactibility and cohesivity of the sample. At the same time the importance of spherical crystallization was stressed for the purpose of the direct pressing of ASA crystals. There was no sign whatsoever of electrostatic charging during the pressing of ASA3. The crystal agglomerates can be compressed to tablets almost in a frictionless manner. This was confirmed by the slight variation of the pressing force, average weight and weight variation value. The extreme hardness of the tablets as well as their small standard deviation also proved the important role of the ASA3 sample.
Conclusions
The typical spherical crystallization process can be used successfully to manufacture spherical crystals of ASA with good flowability, compactibility and cohesivity. The ASA3 crystallization process is optimized concerning the form of the crystal agglomerates and the reproducibility of the product. On the basis of the results this product can be recommended for direct tablet-making.
